VIVOS THERAPEUTICS INC (VVOS) Stock Analyst Earnings Estimates
NASDAQ:VVOS - Nasdaq - US92859E2072 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.02M -5.15% | 13.801M -13.85% | 15.031M 8.91% | 15.606M 3.83% | 19.549M 25.27% | |
| EBITDA YoY % growth | -24.36M -29.99% | -16.675M 31.55% | -10.59M 36.49% | -9.282M 12.35% | -7.038M 24.18% | |
| EBIT YoY % growth | -25.03M -28.56% | -17.296M 30.90% | -11.171M 35.41% | -6.639M 40.57% | -9.08M -36.76% | |
| Operating Margin | -156.24% | -125.32% | -74.32% | -42.54% | -46.44% | |
| EPS YoY % growth | -20.08 -119.69% | -10.92 45.62% | -2.91 73.35% | -1.57 46.02% | -0.95 39.61% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 34.55% | -0.32 20.95% | -0.32 -12.93% | -0.37 18.40% |
| Revenue Q2Q % growth | 3.858M -4.83% | 4.107M 6.40% | 4.216M 14.01% | 4.386M 45.42% |
| EBITDA Q2Q % growth | -2.346M -42.61% | -2.04M 7.61% | -2.142M 3.73% | -2.142M 42.74% |
| EBIT Q2Q % growth | -2.915M -50.58% | -2.68M -1.31% | -2.687M 4.23% | -2.142M 45.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.45 72.39% | -0.41 | -0.04 | -10.29% |
| Q4 2024 Q2Q % growth | -0.28 90.82% | -0.40 | 0.12 | 30.50% |
| Q3 2024 Q2Q % growth | -0.40 75.31% | -0.62 | 0.22 | 35.71% |
| Q2 2024 Q2Q % growth | -0.60 86.67% | -1.07 | 0.47 | 43.98% |
| Q1 2024 Q2Q % growth | -1.63 6.86% | -1.20 | -0.43 | -36.00% |
| Q4 2023 Q2Q % growth | -3.05 39.00% | -1.94 | -1.11 | -56.97% |
| Q3 2023 Q2Q % growth | -1.62 -390.91% | -3.19 | 1.57 | 49.18% |
| Q2 2023 Q2Q % growth | -4.50 45.45% | -3.70 | -0.80 | -21.70% |
| Q1 2023 Q2Q % growth | -1.75 73.08% | -4.59 | 2.84 | 61.87% |
| Q4 2022 Q2Q % growth | -5.00 41.18% | -5.61 | 0.61 | 10.87% |
| Q3 2022 Q2Q % growth | -0.33 -26.92% | -0.27 | -0.06 | -22.09% |
| Q2 2022 Q2Q % growth | -8.25 -4,242.11% | -7.14 | -1.11 | -15.55% |
| Q1 2022 Q2Q % growth | -6.50 -3,321.05% | -6.63 | 0.13 | 1.96% |
| Q4 2021 Q2Q % growth | -8.50 -865.91% | -6.38 | -2.13 | -33.33% |
| Q3 2021 Q2Q % growth | -0.26 | -0.19 | -0.07 | -37.78% |
| Q2 2021 Q2Q % growth | -0.19 | -0.18 | -0.01 | -3.49% |
| Q1 2021 Q2Q % growth | -0.19 | -0.17 | -0.02 | -9.57% |
| Q4 2020 Q2Q % growth | -0.88 | -0.17 | -0.71 | -422.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 3.016M -11.79% | 3.74M | -724K | -19.36% |
| Q4 2024 Q2Q % growth | 3.698M 13.85% | 3.963M | -265K | -6.69% |
| Q3 2024 Q2Q % growth | 3.86M 16.93% | 4.142M | -282K | -6.81% |
| Q2 2024 Q2Q % growth | 4.054M 19.41% | 3.672M | 382K | 10.40% |
| Q1 2024 Q2Q % growth | 3.419M -11.36% | 3.479M | -60K | -1.72% |
| Q4 2023 Q2Q % growth | 3.248M -17.77% | 3.474M | -226K | -6.51% |
| Q3 2023 Q2Q % growth | 3.301M -22.33% | 4.223M | -922K | -21.83% |
| Q2 2023 Q2Q % growth | 3.395M -18.78% | 4.229M | -834K | -19.72% |
| Q1 2023 Q2Q % growth | 3.857M 5.96% | 4.086M | -229K | -5.60% |
| Q4 2022 Q2Q % growth | 3.95M -10.02% | 4.642M | -692K | -14.91% |
| Q3 2022 Q2Q % growth | 4.25M -6.59% | % | ||
| Q2 2022 Q2Q % growth | 4.18M -7.11% | 3.885M | 295K | 7.59% |
| Q1 2022 Q2Q % growth | 3.64M 5.51% | 4.531M | -891K | -19.66% |
| Q4 2021 Q2Q % growth | 4.39M 32.63% | 4.951M | -561K | -11.33% |
| Q3 2021 Q2Q % growth | 4.55M 38.30% | 4.592M | -42K | -0.91% |
| Q2 2021 Q2Q % growth | 4.5M -30.42% | 3.671M | 829K | 22.58% |
| Q1 2021 Q2Q % growth | 3.45M | 3.317M | 133K | 4.01% |
| Q4 2020 Q2Q % growth | 3.31M 8.17% | 3.273M | 37K | 1.13% |
| Q3 2020 Q2Q % growth | 3.29M -0.90% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -16.67% | 0% | -21.26% |
| Revenue | -9.84% | -16.78% | -11.56% | -11.56% |